alt Hacker Newsi think it's a promising ai-shaped problem
you have inputs and outputs mapped for the trials and know historically how trials tend to fail
not a leap to have ai assist in proposing or reviewing trials to reduce failure rates. even a 10% reduction is massive
It's not an AI-shaped problem. The mapping from inputs to outputs is something like "the most complex process humans are aware of." You're trying to map a chemical in a pill (or a shot) from the organism down to organs down to cells, through the metabolome, proteome, genome, and so on, both down then back up, until you get back to "outcome that a human being feels positively about."